SKYE BIOSCIENCE INC (SKYE)

US83086J2006 - Common Stock

2.85  0 (0%)

After market: 2.85 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
28.17M34.89M12.11M7.85M6.29M
Research and Development
12.50M27.03M6.01M2.93M1.94M
Selling, General, and Administrative Expenses
15.67M7.85M6.09M4.92M4.34M
Operating Income
-28.17M-34.89M-12.11M-7.85M-6.29M
Interest Income/Expense
1.12M-806.29K-710.00K-790.00K-270.00K
Other Income/Expense
0.00-1.38MN/AN/AN/A
Non Recurring Items
4.60M-257.51K-6.66M120.00K0.00
Income Before Taxes
-21.23M-37.64M-19.47M-8.52M-6.56M
Income Tax
10.07K3.60K10.00K0.000.00
Net Income
-21.24M-37.64M-19.48M-8.52M-6.56M
EBITDA
-28.02M-34.76M-11.99M-7.82MN/A
 
Per Share Data
EPS Diluted Total Ops
-0.84-5.37-8.77-5.24-7.13
Non GAAP EPS
-1.11N/AN/AN/AN/A
 
Statistics

All data in USD

Charts